Market Place
Sourcing Support
Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study
10 Jun 2024 //
BIOSPACE
Mylan`s Generic Lopinavir and Ritonavir Receives Approval in the U.S.
07 Feb 2024 //
FDA
Pfizer’s COVID-19 oral anti-viral available to more Australians Pharma Benefits
02 Jul 2023 //
NATION ALTRIBUNE
Pfizer`s Paxlovid (nirmatrelvir, ritonavir) Approved In Europe
27 Jun 2023 //
EMA
Ascletis Announces Entering into a Agreement of Ritonavir Tablets with Simcere
16 Jan 2023 //
PR NEWSWIRE
Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir
14 Oct 2022 //
JACC
Pfizer to deliver up to six million courses of Paxlovid to Global Fund
23 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Zenara Pharma Launches Generic Of Paxlovid For COVID-19 In India
09 Sep 2022 //
OUTLOOKINDIA
Sorrento Therapeutics Announces China NMPA IND Clearance of STI-1558
19 Aug 2022 //
GLOBENEWSWIRE
Codexis Announces Agreement with Pfizer to Supply Enzyme for PAXLOVID
14 Jul 2022 //
GLOBENEWSWIRE
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
14 Jun 2022 //
EXPRESS PHARMA
Junshi reports positive Phase III data in mild-to-moderate Covid-19
24 May 2022 //
CLINICALTRIALSARENA
Cipla`s Generic Ritonavir Receives Approval in the U.S.
10 May 2022 //
FDA
WHO recommends highly successful COVID-19 therapy and calls for wide
22 Apr 2022 //
WHO
Aligos Tx Selects ALG-097558 for the Treatment and Prevention of COVID-19
04 Apr 2022 //
GLOBENEWSWIRE
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets
04 Apr 2022 //
PRNEWSWIRE
Ascletis Submits MAA for Ritonavir in Hong Kong
03 Apr 2022 //
PRNEWSWIRE
Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.
21 Mar 2022 //
FDA
Amneal Awarded Sub-License for Generic Version of Nirmatrelvir and Ritonavir
17 Mar 2022 //
BUSINESSWIRE
Ascletis Expands Ritonavir Oral Tablet Production Capacity to 530M Tablets/Year
13 Mar 2022 //
PRNEWSWIRE
Ascletis seeks marketing authorisation for ritonavir in eight European countries
02 Mar 2022 //
PHARMACEUTICAL-TECHNOLOGY
RESCUEVID (Nirmatrelvir & Ritonavir tablets)
21 Feb 2022 //
PRESS RELEASE
Modra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r
17 Feb 2022 //
BUSINESSWIRE
China gives conditional approval to Pfizer`s oral COVID-19 drug
16 Feb 2022 //
BIOSPECTRUMASIA
Ascletis Submits MAA for Ritonavir in Multiple European Countries
13 Feb 2022 //
PRNEWSWIRE
Pfizer`s Paxlovid (ritonavir) Receives Approval in Europe.
28 Jan 2022 //
EMA
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
27 Jan 2022 //
BUSINESSWIRE
Australian TGA grants approval to two oral medicines for Covid-19
20 Jan 2022 //
PHARMACEUTICAL-TECHNOLOGY
Ascletis Signs Ritonavir Tablet Purchase Agreement with Phokam Pharmaceutical
18 Jan 2022 //
BIOSPACE
Ritonavir production to reach 100M doses annually; and more
06 Jan 2022 //
ENDPTS
Ascletis Expands Ritonavir Production; Lines Antivirals Against SARS-CoV-2 Virus
02 Jan 2022 //
PRNEWSWIRE
US FDA authorises first oral antiviral to treat COVID
22 Dec 2021 //
EXPRESSPHARMA
Pfizer to Provide UK Additional 2.5M Oral Antiviral Doses to aid combat COVID-19
21 Dec 2021 //
BUSINESSWIRE
Pfizer’s Paxlovid can be used for the treatment of COVID-19, says EMA
20 Dec 2021 //
EUROPEANPHARMACEUTICALREVIEW
Pfizer shares efficacy of COVID pill:near 90% against hospitalisation
15 Dec 2021 //
PHARMAFILE
Pfizer Requests Emergency Use Authorization for Oral Antiviral Paxlovid
17 Nov 2021 //
TRIALSITENEWS
What`s the oral antiviral market for endemic COVID-19?
07 Oct 2021 //
FIERCEPHARMA
TGA grants, Pfizer Australia`s COVID-19 treatment PF-07321332 + ritonavir
05 Oct 2021 //
TGA
Pfizer`s oral COVID-19 antiviral gets rolling in phase 2/3 trial
28 Sep 2021 //
FIERCEBIOTECH
Laurus Labs, Unitaid and CHAI ink agreement for development of HIV medication
14 Sep 2021 //
PHARMABIZ
Hetero Labs Ltd Iii`s Generic Lopinavir; Ritonavir Receives Approval In US
04 Jun 2021 //
FDA
Enforcement Report - Week of June 2, 2021
02 Jun 2021 //
FDA
Repurposed drugs not effective treatment for hospitalised COVID-19, WHO says
20 Oct 2020 //
EUROPEANPHARMACEUTICALSREVIEW
Gilead refutes WHO’s claim over remdesivir’s efficacy
19 Oct 2020 //
KOREABIOMED
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
16 Oct 2020 //
PHARMAPHORUM
Hybridized nanoamorphous micellar dispersion using a QbD–DM3 linked
24 Aug 2020 //
PHARMAEXCIPIENTS
Pharming announces enrolment of first patient in multinational trial RUCONEST®
10 Aug 2020 //
PRNEWSWIRE
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms
06 Jul 2020 //
WHO
No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19
30 Jun 2020 //
RECOVERYTRIAL
Coronavirus: Hydroxychloroquine trial to restart
30 Jun 2020 //
BBC
Antiviral hyped as potential Covid treatment "ineffective", finds major study
29 Jun 2020 //
ECONOMICTIMES
After Kaletra setback, AbbVie joins forces for COVID hopeful pe
08 Jun 2020 //
FIERCE BIOTECH
UK spent £20m buying up stocks of HIV and malaria drugs
14 May 2020 //
THEGUARDIAN
Triple drug combination shows promise in Covid-19 treatment
11 May 2020 //
CLINICALTRIALSARENA
CSIR submits 53 genome sequences of coronavirus to global body
06 May 2020 //
ECONOMICTIMES
Traumakine to be a part of WHO’s Solidarity trial
27 Apr 2020 //
CISION
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
22 Apr 2020 //
FORBES
In Russia, a black market for HIV drug to try on coronavirus
21 Apr 2020 //
REUTERS
Positive results from initial lopinavir-ritonavir COVID-19 clinical trial
08 Apr 2020 //
CLINICALTRIALSARENA
Mylan waives exclusive US distribution rights for potential COVID-19 therapy
26 Mar 2020 //
REUTERS
